Additional Supporting Information can be found in the online version of this article.

ANA_22673_sm_SuppInfo_clinical_evaluations.doc26KSupporting Information
ANA_22673_sm_SuppInfo_methods.doc56KSupporting Information
ANA_22673_sm_SuppInfoFig1.pdf614KSupporting Information Figure 1: (A-C) The MRI and MRS brain images showing somewhat thinned corpus callosum and normal peaks of creatine, lactate, and N-acetylaspartate in left frontal lobe.
ANA_22673_sm_SuppInfoFig2.pdf297KSupporting Information Figure 2. X-Inactivation assays and aCGH results for grandmothers from family I and II and great grandmother from family I.
ANA_22673_sm_SuppInfoTab1.pdf377KSupplementary Table 1: List of 139 genes within the duplication at Xq12-q13.3
ANA_22673_sm_SuppInfoTab2.pdf262KSupplementary Table 2: Genes dysregulated in patients compared to controls
ANA_22673_sm_SuppInfoTab3.pdf635KSupplementary Table 3: Common genes between validation datasets and our global expression profiling analysis
ANA_22673_sm_SuppInfoTab4.pdf321KSupplementary Table 4: The overrepresented functional categories and disorders associated with common genes between independent ASD validation datasets and our differentially expressed genes.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.